These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 16115127)

  • 1. Phosphoinositide 3-kinase/Akt inhibition increases arsenic trioxide-induced apoptosis of acute promyelocytic and T-cell leukaemias.
    Tabellini G; Tazzari PL; Bortul R; Evangelisti C; Billi AM; Grafone T; Martinelli G; Baccarani M; Martelli AM
    Br J Haematol; 2005 Sep; 130(5):716-25. PubMed ID: 16115127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arsenic trioxide induces apoptosis in leukemia/lymphoma cell lines via the CD95/CD95L system.
    Zhu J; Okumura H; Ohtake S; Nakamura S; Nakao S
    Oncol Rep; 2003; 10(3):705-9. PubMed ID: 12684647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination of the differential chemoresistance between the murine B-cell lymphoma LY-ar and LY-as cell lines after arsenic (As2O3) exposure via the overexpression of gsto1 (p28).
    Giri U; Terry NH; Kala SV; Lieberman MW; Story MD
    Cancer Chemother Pharmacol; 2005 Jun; 55(6):511-21. PubMed ID: 15761769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells.
    Tabellini G; Cappellini A; Tazzari PL; Falà F; Billi AM; Manzoli L; Cocco L; Martelli AM
    J Cell Physiol; 2005 Feb; 202(2):623-34. PubMed ID: 15316930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of intracellular arsenic trioxide for therapeutic response in acute promyelocytic leukemia.
    Sahu GR; Jena RK
    Am J Hematol; 2005 Feb; 78(2):113-6. PubMed ID: 15682419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deguelin, A PI3K/AKT inhibitor, enhances chemosensitivity of leukaemia cells with an active PI3K/AKT pathway.
    Bortul R; Tazzari PL; Billi AM; Tabellini G; Mantovani I; Cappellini A; Grafone T; Martinelli G; Conte R; Martelli AM
    Br J Haematol; 2005 Jun; 129(5):677-86. PubMed ID: 15916691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of GSTP1-1 in mediating the effect of As2O3 in the Acute Promyelocytic Leukemia cell line NB4.
    Bernardini S; Nuccetelli M; Noguera NI; Bellincampi L; Lunghi P; Bonati A; Mann K; Miller WH; Federici G; Lo Coco F
    Ann Hematol; 2006 Oct; 85(10):681-7. PubMed ID: 16733740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of p38 MAPK and JNK in Arsenic trioxide-induced mitochondrial cell death in human cervical cancer cells.
    Kang YH; Lee SJ
    J Cell Physiol; 2008 Oct; 217(1):23-33. PubMed ID: 18412143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
    Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
    Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCR-ABL mediates arsenic trioxide-induced apoptosis independently of its aberrant kinase activity.
    Puccetti E; Güller S; Orleth A; Brüggenolte N; Hoelzer D; Ottmann OG; Ruthardt M
    Cancer Res; 2000 Jul; 60(13):3409-13. PubMed ID: 10910048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of arsenic trioxide resistant clones derived from Jurkat leukemia T cell line: focus on PI3K/Akt signaling pathway.
    Roszak J; Smok-Pieniążek A; Nocuń M; Stępnik M
    Chem Biol Interact; 2013 Oct; 205(3):198-211. PubMed ID: 23911876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Latent membrane protein-1 of Epstein - Barr virus increases sensitivity to arsenic trioxide-induced apoptosis in nasopharyngeal carcinoma cell.
    Du CW; Wen BG; Li DR; Lin YC; Zheng YW; Chen L; Chen JY; Lin W; Wu MY
    Exp Oncol; 2005 Dec; 27(4):267-72. PubMed ID: 16404345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arsenic trioxide induces regulated, death receptor-independent cell death through a Bcl-2-controlled pathway.
    Scholz C; Richter A; Lehmann M; Schulze-Osthoff K; Dörken B; Daniel PT
    Oncogene; 2005 Oct; 24(47):7031-42. PubMed ID: 16007134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic enhances the activation of Stat1 by interferon gamma leading to synergistic expression of IRF-1.
    Chelbi-alix MK; Bobé P; Benoit G; Canova A; Pine R
    Oncogene; 2003 Dec; 22(57):9121-30. PubMed ID: 14668793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arsenic trioxide represses NF-kappaB activation and increases apoptosis in ATRA-treated APL cells.
    Mathieu J; Besançon F
    Ann N Y Acad Sci; 2006 Dec; 1090():203-8. PubMed ID: 17384263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leishmania promastigotes activate PI3K/Akt signalling to confer host cell resistance to apoptosis.
    Ruhland A; Leal N; Kima PE
    Cell Microbiol; 2007 Jan; 9(1):84-96. PubMed ID: 16889626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic trioxide induces apoptosis through a reactive oxygen species-dependent pathway and loss of mitochondrial membrane potential in HeLa cells.
    Woo SH; Park IC; Park MJ; Lee HC; Lee SJ; Chun YJ; Lee SH; Hong SI; Rhee CH
    Int J Oncol; 2002 Jul; 21(1):57-63. PubMed ID: 12063550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arsenic trioxide-induced apoptosis is independent of CD95 in lymphatic cell lines.
    Rojewski MT; Körper S; Thiel E; Schrezenmeier H
    Oncol Rep; 2004 Feb; 11(2):509-13. PubMed ID: 14719092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of class I phosphoinositide 3-kinase activity impairs proliferation and triggers apoptosis in acute promyelocytic leukemia without affecting atra-induced differentiation.
    Billottet C; Banerjee L; Vanhaesebroeck B; Khwaja A
    Cancer Res; 2009 Feb; 69(3):1027-36. PubMed ID: 19176369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arsenic trioxide triggers a regulated form of caspase-independent necrotic cell death via the mitochondrial death pathway.
    Scholz C; Wieder T; Stärck L; Essmann F; Schulze-Osthoff K; Dörken B; Daniel PT
    Oncogene; 2005 Mar; 24(11):1904-13. PubMed ID: 15674346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.